{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:27:23Z","timestamp":1792790843726,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T00:00:00Z","timestamp":1666915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T00:00:00Z","timestamp":1666915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007709","name":"Michigan State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007709","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Genomic Prediction, Inc.","id":[{"id":"https:\/\/ror.org\/03q8q6n37","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We construct a polygenic health index as a weighted sum of polygenic risk scores for 20 major disease conditions, including, e.g., coronary artery disease, type 1 and 2 diabetes, schizophrenia, etc. Individual weights are determined by population-level estimates of impact on life expectancy. We validate this index in odds ratios and selection experiments using unrelated individuals and siblings (pairs and trios) from the UK Biobank. Individuals with higher index scores have decreased disease risk across almost all 20 diseases (no significant risk increases), and longer calculated life expectancy. When estimated Disability Adjusted Life Years (DALYs) are used as the performance metric, the gain from selection among ten individuals (highest index score vs average) is found to be roughly 4 DALYs. We find no statistical evidence for antagonistic trade-offs in risk reduction across these diseases. Correlations between genetic disease risks are found to be mostly positive and generally mild. These results have important implications for public health and also for fundamental issues such as pleiotropy and genetic architecture of human disease conditions.<\/jats:p>","DOI":"10.1038\/s41598-022-22637-8","type":"journal-article","created":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T09:13:07Z","timestamp":1666948387000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Polygenic Health Index, General Health, and Pleiotropy: Sibling Analysis and Disease Risk Reduction"],"prefix":"10.1038","volume":"12","author":[{"given":"Erik","family":"Widen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Lello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy G.","family":"Raben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent C. A. M.","family":"Tellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D. H.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,28]]},"reference":[{"key":"22637_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-020-00742-5","volume":"12","author":"CM Lewis","year":"2020","unstructured":"Lewis, C. M. & Vassos, E. Polygenic risk scores: From research tools to clinical instruments. Genome Med. 12, 1\u201311 (2020).","journal-title":"Genome Med."},{"key":"22637_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-021-00829-7","volume":"13","author":"AC Lewis","year":"2021","unstructured":"Lewis, A. C. & Green, R. C. Polygenic risk scores in the clinic: New perspectives needed on familiar ethical issues. Genome Med. 13, 1\u201310 (2021).","journal-title":"Genome Med."},{"key":"22637_CR3","doi-asserted-by":"crossref","unstructured":"Richardson, T. G., Harrison, S., Hemani, G. & Smith, G. D. An atlas of polygenic risk score associations to highlight putative causal relationships across the human phenome. eLife 8, e43657 (2019).","DOI":"10.7554\/eLife.43657"},{"key":"22637_CR4","doi-asserted-by":"crossref","unstructured":"Wray, N. R. et al. From basic science to clinical application of polygenic risk scores: A primer. JAMA Psychiatry. https:\/\/doi.org\/10.1001\/jamapsychiatry.2020.3049 (2020)","DOI":"10.1001\/jamapsychiatry.2020.3049"},{"key":"22637_CR5","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41576-018-0018-x","volume":"19","author":"A Torkamani","year":"2018","unstructured":"Torkamani, A., Wineinger, N. E. & Topol, E. J. The personal and clinical utility of polygenic risk scores. Nat. Rev. Genet. 19, 581 (2018).","journal-title":"Nat. Rev. Genet."},{"key":"22637_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-37186-2","volume":"9","author":"L Lello","year":"2019","unstructured":"Lello, L., Raben, T. G., Yong, S. Y., Tellier, L. C. & Hsu, S. D. H. Genomic prediction of 16 complex disease risks including heart attack, diabetes, breast and prostate cancer. Sci. Rep. 9, 1\u201316 (2019).","journal-title":"Sci. Rep."},{"key":"22637_CR7","doi-asserted-by":"crossref","unstructured":"Widen, E., Raben, T. G., Lello, L. & Hsu, S. D. H. Machine learning prediction of biomarkers from SNPs and of disease risk from biomarkers in the UK biobank. Genes 12. ISSN: 2073-4425. https:\/\/www.mdpi.com\/2073-4425\/12\/7\/991 (2021).","DOI":"10.3390\/genes12070991"},{"key":"22637_CR8","doi-asserted-by":"publisher","first-page":"1000864","DOI":"10.1371\/journal.pgen.1000864","volume":"6","author":"NR Wray","year":"2010","unstructured":"Wray, N. R., Yang, J., Goddard, M. E. & Visscher, P. M. The genetic interpretation of area under the ROC curve in genomic profiling. PLoS Genet. 6, 1000864 (2010).","journal-title":"PLoS Genet."},{"key":"22637_CR9","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1097\/GIM.0b013e3181eff533","volume":"12","author":"DL Veenstra","year":"2010","unstructured":"Veenstra, D. L., Roth, J. A., Garrison Jr, L. P., Ramsey, S. D. & Burke, W. A formal risk 493 benefit framework for genomic tests: Facilitating the appropriate translation of genomics into clinical practice. Genet. Med. 12, 686 (2010).","journal-title":"Genet. Med."},{"key":"22637_CR10","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/jnci\/djq088","volume":"102","author":"E Amir","year":"2010","unstructured":"Amir, E., Freedman, O. C., Seruga, B. & Evans, D. G. Assessing women at high risk of breast cancer: A review of risk assessment models. JNCI J. Natl. Cancer Inst. 102, 680\u2013691 (2010).","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"22637_CR11","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1093\/bioinformatics\/btu848","volume":"31","author":"J Euesden","year":"2014","unstructured":"Euesden, J., Lewis, C. M. & Oreilly, P. F. PRSice: Polygenic risk score software. Bioinformatics 31, 1466\u20131468 (2014).","journal-title":"Bioinformatics"},{"key":"22637_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pgen.1004137","volume":"10","author":"G Abraham","year":"2014","unstructured":"Abraham, G. et al. Accurate and robust genomic prediction of celiac disease using statistical learning. PLOS Genet. 10, 1\u201315. https:\/\/doi.org\/10.1371\/journal.pgen.1004137 (2014).","journal-title":"PLOS Genet."},{"key":"22637_CR13","doi-asserted-by":"crossref","unstructured":"Priest, J. R. & Ashley, E. A. Genomics in clinical practice (2014).","DOI":"10.1136\/heartjnl-2014-306111"},{"key":"22637_CR14","first-page":"5194cm5","volume":"21","author":"HJ Jacob","year":"2013","unstructured":"Jacob, H. J. et al. Genomics in clinical practice: Lessons from the front lines. Sci. Translat. Med. 21, 5194cm5 (2013).","journal-title":"Sci. Translat. Med."},{"key":"22637_CR15","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s10549-016-3953-2","volume":"159","author":"Y Shieh","year":"2016","unstructured":"Shieh, Y. et al. Breast cancer risk prediction using a clinical risk model and polygenic risk score. Breast Cancer Res. Treat. 159, 513\u2013525 (2016).","journal-title":"Breast Cancer Res. Treat."},{"key":"22637_CR16","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/gim.2016.17","volume":"18","author":"S Bowdin","year":"2016","unstructured":"Bowdin, S. et al. Recommendations for the integration of genomics into clinical practice. Genet. Med. 18, 1075 (2016).","journal-title":"Genet. Med."},{"key":"22637_CR17","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrg.2016.27","volume":"17","author":"N Chatterjee","year":"2016","unstructured":"Chatterjee, N., Shi, J. & Garc\u00eda-Closas, M. Developing and evaluating polygenic risk prediction models for stratified disease prevention. Nat. Rev. Genet. 17, 392 (2016).","journal-title":"Nat. Rev. Genet."},{"key":"22637_CR18","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41581-018-0067-6","volume":"14","author":"L Liu","year":"2018","unstructured":"Liu, L. & Kiryluk, K. Genome-wide polygenic risk predictors for kidney disease. Nat. Rev. Nephrol. 14, 723\u2013724 (2018).","journal-title":"Nat. Rev. Nephrol."},{"key":"22637_CR19","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1001\/jama.2019.8430","volume":"322","author":"HD Nelson","year":"2019","unstructured":"Nelson, H. D., Pappas, M., Cantor, A., Haney, E. & Holmes, R. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: Updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 322, 666\u2013685 (2019).","journal-title":"JAMA"},{"key":"22637_CR20","doi-asserted-by":"crossref","unstructured":"Kulm, S., Marderstein, A., Mezey, J. & Elemento, O. A systematic framework for assessing the clinical impact of polygenic risk scores. medRxiv 2020-04 (2021).","DOI":"10.1101\/2020.04.06.20055574"},{"key":"22637_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1001\/jamapsychiatry.2020.3049","volume":"78","author":"NR Wray","year":"2021","unstructured":"Wray, N. R. et al. From basic science to clinical application of polygenic risk scores: A primer. JAMA Psychiatry 78, 101\u2013109 (2021).","journal-title":"JAMA Psychiatry"},{"key":"22637_CR22","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ajhg.2020.07.002","volume":"107","author":"A Meisner","year":"2020","unstructured":"Meisner, A. et al. Combined utility of 25 disease and risk factor polygenic risk scores for stratifying risk of all-cause mortality. Am. J. Hum. Genet. 107, 418\u2013431 (2020).","journal-title":"Am. J. Hum. Genet."},{"key":"22637_CR23","doi-asserted-by":"crossref","unstructured":"Jukarainen, S., Kiiskinen, T., Havulinna, A. S. & Karjalainen, J. Genetic risk factors have a substantial impact on healthy life years. medRxiv 1\u201355. https:\/\/www.medrxiv.orgcontent\/10.1101\/2022.01.25.22269831v1 (2022).","DOI":"10.1101\/2022.01.25.22269831"},{"key":"22637_CR24","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00439-019-02033-5","volume":"138","author":"DC Crawford","year":"2019","unstructured":"Crawford, D. C., Cooke Bailey, J. N. & Briggs, F. Mind the gap: Resources required to receive, process and interpret research-returned whole genome data. Hum. Genet. 138, 691\u2013701 (2019).","journal-title":"Hum. Genet."},{"key":"22637_CR25","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1089\/gtmb.2012.0350","volume":"17","author":"SB Haga","year":"2013","unstructured":"Haga, S. B. et al. Public knowledge of and attitudes toward genetics and genetic testing. Genet. Test. Mol. Biomark. 17, 327\u2013335 (2013).","journal-title":"Genet. Test. Mol. Biomark."},{"key":"22637_CR26","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/gim.2013.14","volume":"15","author":"B Hurle","year":"2013","unstructured":"Hurle, B. et al. What does it mean to be genomically literate?: National Human Genome Research Institute meeting report. Genet. Med. 15, 658\u2013663 (2013).","journal-title":"Genet. Med."},{"key":"22637_CR27","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000294191","volume":"14","author":"DH Lea","year":"2011","unstructured":"Lea, D. H., Kaphingst, K. A., Bowen, D., Lipkus, I. & Hadley, D. W. Communicating genetic and genomic information: Health literacy and numeracy considerations. Public Health Genomics 14, 279\u2013289 (2011).","journal-title":"Public Health Genomics"},{"key":"22637_CR28","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/jgc4.1348","volume":"30","author":"AA Dwyer","year":"2021","unstructured":"Dwyer, A. A. et al. Evaluating co-created patient-facing materials to increase under standing of genetic test results. J. Genet. Counsel. 30, 598\u2013605 (2021).","journal-title":"J. Genet. Counsel."},{"key":"22637_CR29","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41436-018-0097-2","volume":"21","author":"T Moscarello","year":"2019","unstructured":"Moscarello, T., Murray, B., Reuter, C. M. & Demo, E. Direct-to-consumer raw genetic data and third-party interpretation services: More burden than bargain?. Genet. Med. 21, 539\u2013541 (2019).","journal-title":"Genet. Med."},{"key":"22637_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.551","volume":"7","author":"KW Davis","year":"2019","unstructured":"Davis, K. W., Hamby Erby, L., Fiallos, K., Martin, M. & Wassman, E. R. A comparison of genomic laboratory reports and observations that may enhance their clinical utility for providers and patients. Mol. Genet. Genomic Med. 7, e00551 (2019).","journal-title":"Mol. Genet. Genomic Med."},{"key":"22637_CR31","doi-asserted-by":"publisher","first-page":"S224","DOI":"10.1542\/peds.2013-1032G","volume":"132","author":"C Kaye","year":"2013","unstructured":"Kaye, C. & Korf, B. Genetic literacy and competency. Pediatrics 132, S224\u2013S230 (2013).","journal-title":"Pediatrics"},{"key":"22637_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.pec.2008.05.009","volume":"73","author":"L Henneman","year":"2008","unstructured":"Henneman, L., Marteau, T. M. & Timmermans, D. R. Clinical geneticists\u2019 and genetic counselors\u2019 views on the communication of genetic risks: A qualitative study. Patient Educ. Counsel. 73, 42\u201349 (2008).","journal-title":"Patient Educ. Counsel."},{"key":"22637_CR33","doi-asserted-by":"crossref","unstructured":"The alarming rise of complex genetic testing in human embryo selection. Nature 603, 549\u2013550 (2022).","DOI":"10.1038\/d41586-022-00787-z"},{"key":"22637_CR34","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41431-021-01000-x","volume":"30","author":"F Forzano","year":"2022","unstructured":"Forzano, F. et al. The use of polygenic risk scores in pre-implantation genetic testing: an unproven, unethical practice. Eur J Hum Genet 30, 493\u2013495. https:\/\/doi.org\/10.1038\/s41431-021-01000-x (2022).","journal-title":"Eur J Hum Genet"},{"key":"22637_CR35","doi-asserted-by":"publisher","first-page":"e398","DOI":"10.3399\/bjgp19X702725","volume":"69","author":"J Buddeke","year":"2019","unstructured":"Buddeke, J. et al. Comorbidity in patients with cardiovascular disease in primary care: A cohort study with routine healthcare data. Eng. Br. J. Gen. Pract. 69, e398\u2013e406 (2019) ((ISSN:1478-5242 (Electronic); 0960-1643 (Print); 0960-1643 (Linking))).","journal-title":"Eng. Br. J. Gen. Pract."},{"key":"22637_CR36","unstructured":"Institute of Medicine. Cardiovascular Disability: Updating the Social Security Listings. ISBN: 978-0-309-15698-1. https:\/\/nap.nationalacademies.org\/catalog\/12940\/cardiovasculardisability-updating-the-social-security-listings. (The National Academies Press, 2010)."},{"key":"22637_CR37","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1751-7176.2011.00434.x","volume":"13","author":"AN Long","year":"2011","unstructured":"Long, A. N. & Dagogo-Jack, S. Comorbidities of diabetes and hypertension: Mechanisms and approach to target organ protection. Eng. J. Clin. Hypertens. (Greenwich) 13, 244\u2013251 (2011) ((ISSN: 1751-7176 (Electronic); 1524-6175 (Print); 1524-6175 (Linking))).","journal-title":"Eng. J. Clin. Hypertens. (Greenwich)"},{"key":"22637_CR38","doi-asserted-by":"crossref","unstructured":"B\u00e4hler, C., Schoepfer, A. M., Vavricka, S. R., Br\u00fcngger, B. & Reich, O. Chronic comorbidities associated with inflammatory bowel disease: Prevalence and impact on healthcare costs in Switzerland. Eur. J. Gastroenterol. Hepatol. 29. https: \/\/journals.lww.com\/eurojgh\/Fulltext\/2017\/08000\/Chronic_comorbidities_ associated_with_inflammatory.8.aspx (2017).","DOI":"10.1097\/MEG.0000000000000891"},{"key":"22637_CR39","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3233\/JAD-170786","volume":"63","author":"J-H Wang","year":"2018","unstructured":"Wang, J.-H., Wu, Y.-J., Tee, B. L. & Lo, R. Y. Medical comorbidity in Alzheimer\u2019s disease: A nested case-control study. Eng. J. Alzheimers Dis. 63, 773\u2013781 (2018) ((ISSN: 1875- 8908 (Electronic); 1387-2877 (Linking) )).","journal-title":"Eng. J. Alzheimers Dis."},{"key":"22637_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.631770","volume":"13","author":"JA Santiago","year":"2021","unstructured":"Santiago, J. A. & Potashkin, J. A. The impact of disease comorbidities in Alzheimer\u2019s disease. Eng. Front. Aging Neurosci. 13, 631770 (2021) ((ISSN: 1663-4365 (Print); 1663-4365 (Electronic); 1663-4365 (Linking) )).","journal-title":"Eng. Front. Aging Neurosci."},{"key":"22637_CR41","doi-asserted-by":"crossref","unstructured":"Al-Asadi, A. M., Klein, B. & Meyer, D. Multiple comorbidities of 21 psychological disorders and relationships with psychosocial variables: a study of the online assessment and diagnostic system within a web-based population. J. Med. Internet Res. 17, e55\u2013e55. https:\/\/pubmed.ncbi.nlm.nih.gov\/25803420 (2015).","DOI":"10.2196\/jmir.4143"},{"key":"22637_CR42","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","volume":"62","author":"RC Kessler","year":"2005","unstructured":"Kessler, R. C., Chiu, W. T., Demler, O., Merikangas, K. R. & Walters, E. E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Eng. Arch. Gen. Psychiatry 62, 617\u2013627 (2005) ((ISSN: 0003-990X (Print); 1538-3636 (Electronic); 0003-990X (Linking))).","journal-title":"Eng. Arch. Gen. Psychiatry"},{"key":"22637_CR43","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.comppsych.2004.10.005","volume":"46","author":"A Farabaugh","year":"2005","unstructured":"Farabaugh, A. et al. Relationships between major depressive disorder and comorbid anxiety and personality disorders. Eng. Compr. Psychiatry 46, 266\u2013271 (2005) ((ISSN: 0010-440X (Print); 0010-440X (Linking))).","journal-title":"Eng. Compr. Psychiatry"},{"key":"22637_CR44","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1017\/S0033291706008452","volume":"36","author":"T Slade","year":"2006","unstructured":"Slade, T. & Watson, D. The structure of common DSM-IV and ICD-10 mental disorders in the Australian general population. Eng. Psychol. Med. 36, 1593\u20131600 (2006) ((ISSN: 0033-2917 (Print); 0033-2917 (Linking) (2006))).","journal-title":"Eng. Psychol. Med."},{"key":"22637_CR45","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1001\/archpsyc.58.6.597","volume":"58","author":"WA Vollebergh","year":"2001","unstructured":"Vollebergh, W. A. et al. The structure and stability of common mental disorders: The NEMESIS study. Eng. Arch Gen Psychiatry 58, 597\u2013603 (2001) ((ISSN: 0003-990X (Print); 0003- 990X (Linking))).","journal-title":"Eng. Arch Gen Psychiatry"},{"key":"22637_CR46","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/schbul\/sbn135","volume":"35","author":"PF Buckley","year":"2009","unstructured":"Buckley, P. F., Miller, B. J., Lehrer, D. S. & Castle, D. J. Psychiatric comorbidities and schizophrenia. Eng. Schizophr. Bull. 35, 383\u2013402 (2009) ((ISSN: 0586-7614 (Print); 1745-1701 (Electronic); 0586-7614 (Linking))).","journal-title":"Eng. Schizophr. Bull."},{"key":"22637_CR47","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41588-019-0379-x","volume":"51","author":"AR Martin","year":"2019","unstructured":"Martin, A. R. et al. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat. Genet. 51, 584 (2019).","journal-title":"Nat. Genet."},{"key":"22637_CR48","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ajhg.2021.11.008","volume":"109","author":"F Priv\u00e9","year":"2022","unstructured":"Priv\u00e9, F. et al. Portability of 245 polygenic scores when derived from the UK Biobank and applied to 9 ancestry groups from the same cohort. Am. J. Hum. Genet. 109, 12\u201323 (2022) ((ISSN: 15376605)).","journal-title":"Am. J. Hum. Genet."},{"key":"22637_CR49","doi-asserted-by":"crossref","unstructured":"Weissbrod, O. et al. Leveraging fine-mapping and multipopulation training data to improve cross-population polygenic risk scores. Nat. Genet. 54. ISSN: 1061-4036 (2022).","DOI":"10.1038\/s41588-022-01036-9"},{"key":"22637_CR50","doi-asserted-by":"crossref","unstructured":"Shi, H. et al. Population-specific causal disease effect sizes in functionally important regions impacted by selection. Nat. Commun. ISSN: 20411723.http:\/\/dx.doi.org\/10.1038\/s41467-021-21286-1 (2021).","DOI":"10.1038\/s41467-021-21286-1"},{"key":"22637_CR51","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1515\/raon-2016-0021","volume":"51","author":"J Gugic","year":"2017","unstructured":"Gugic, J., Zaletel, L. Z. & Oblak, I. Treatment-related cardiovascular toxicity in long term survivors of testicular cancer. Eng. Radiol. Oncol. 51, 221\u2013227 (2017) ((ISSN: 1318-2099 (Print); 1581-3207 (Electronic); 1318-2099 (Linking))).","journal-title":"Eng. Radiol. Oncol."},{"key":"22637_CR52","doi-asserted-by":"crossref","unstructured":"Feldman, D. R. et al. Predicting cardiovascular disease among testicular cancer survivors after modern cisplatin-based chemotherapy: Application of the Framingham risk score. Clin. Genitour. Cancer 16, e761\u2013e769. https:\/\/pubmed.ncbi.nlm.nih.gov\/29534941 (2018).","DOI":"10.1016\/j.clgc.2018.01.011"},{"key":"22637_CR53","doi-asserted-by":"publisher","first-page":"257","DOI":"10.6004\/jnccn.2017.7046","volume":"16","author":"MA Zaid","year":"2018","unstructured":"Zaid, M. A. et al. Clinical and genetic risk factors for adverse metabolic outcomes in North American testicular cancer survivors. J. Natl. Compr. Cancer Netw. 16, 257\u2013265 (2018).","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"22637_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-68881-8","volume":"10","author":"SY Yong","year":"2020","unstructured":"Yong, S. Y., Raben, T. G., Lello, L. & Hsu, S. D. Genetic architecture of complex traits and disease risk predictors. Sci. Rep. 10, 1\u201314 (2020).","journal-title":"Sci. Rep."},{"key":"22637_CR55","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrg3118","volume":"13","author":"G Gibson","year":"2012","unstructured":"Gibson, G. Rare and common variants: Twenty arguments. Nat. Rev. Genet. 13, 135\u2013145 (2012).","journal-title":"Nat. Rev. Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22637-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22637-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22637-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T01:03:24Z","timestamp":1667005404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-22637-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,28]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["22637"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-22637-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.06.15.22276102","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,28]]},"assertion":[{"value":"5 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: SH is a founder, shareholder, and serves on the Board of Directors of Genomic Prediction, Inc. (GP). LT is a founder, shareholder, serves on the Board of Directors, and is the CEO of GP. EW and LL are employees and shareholders of GP. TR declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18173"}}